Zepto Life Technology Wins NIAID Contract for FungiFlex
St. Paul, Minnesota, August,11, 2026 Zepto Life Technology has been awarded a contract valued at up to $8.9 million...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
St. Paul, Minnesota, August,11, 2026 Zepto Life Technology has been awarded a contract valued at up to $8.9 million...
San Diego, California, USA, August 8, 2026 Blacksmith Medicines has announced the publication of new research in the Journal...
SAN FRANCISCO, Calif., July 27, 2026 Revagenix, Inc. announced that the first participant has been dosed in the Phase...
SAN ANTONIO, Texas, July 14, 2026 Valion Bio, Inc. has announced major strategic progress across its Entolimod platform, advancing...
SOUTH SAN FRANCISCO, Calif., July 6, 2026 Vaxart, Inc. has announced positive topline 12-month safety results from the approximately...
San Antonio, Texas, March 26, 2026 In a strategic move to address critical gaps in radiation emergency therapeutics, Tivic...
